Effect of nucleated marrow cell dose on relapse survival in identical twin bone marrow transplants for leukemia

Blood

Volumn 95, Issue 11, 2000, Pages 3323-3327

  Barrett, A John ^b   Ringdén, Olle ^b   Zhang, Mei Jie ^b   Bashey, Asad ^b   Cahn, Jean Yves ^b   Cairo, Mitchell S ^b   Gale, Robert Peter ^b   Gratwohl, Alois ^b   Locatelli, Franco ^b   Martino, Rodrigo ^b   Schultz, Kirk R ^b   Tiberghien, Pierre ^b   Horowitz, Mary M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; FOLLOW UP; HUMAN; LEUKEMIA; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MONOZYGOTIC TWINS; MORTALITY; PRIORITY JOURNAL; RELAPSE; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL NUCLEUS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REGISTRIES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION, ISOGENEIC; TWINS, MONOZYGOTIC;

EID: 0034210638     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Weiden PL, Flournoy N, Thomas ED, et al. Anti-leukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med. 1979;300:1068.
2. Gale RP, Horowitz MM, Ash RC, et al. Identical twin bone marrow transplants for leukemia. Ann Intern Med. 1994;120:646.
3. Mavroudis D, Fox M, Read EJ, Carter C, Barrett AJ. Effect of CD34 cell dose on outcome following T-depleted marrow transplantation. Blood. 1996; 88:3223.
4. Ringdén O, Nilsson B. Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose and splenectomy. Transplantation. 1985;40:39.
5. Paulin T. Importance of bone marrow cell dose in bone marrow transplantation. Clin Transplant. 1992;6:48.
6. Sierra J, Storer B, Hansen JA, et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemia burden, donor HLA-matching and marrow cell dose. Blood. 1997;89:4226.
7. Kay HEM, Lumley H, Clink HM, Powles RL. Ratio of blood and marrow-derived cells in bone marrow transplantation. J Clin Pathol. 1982; 35:492.
8. Batinic D, Marusic M, Pavletic M, et al. Relationship between differing volumes of bone marrow aspirates and their cellular composition. Bone Marrow Transplant. 1990;6:103.
9. Andersen PK, Borgan O, Gill RD, Keiding N. Statistical Models Based on Counting Processes. New York: Springer-Verlag; 1991.
10. Cox DR. Regression models and life tables. J Roy Stat Soc B. 1972;34:187.
11. Uchida N, Tsukamoto A, He D, Friera AM, Scollay R, Weissman IL. High doses of purified stem cells cause early hematopoiebc recovery in syngeneic and allogeneic hosts. J Clin Invest. 1998;101: 961.
12. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1991;75:555.
13. Fefer A, Cheever MA, Greenberg PD, et al. Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twins. N Engl J Med. 1982;306:63.
14. Fefer A, Cheever MA, Thomas ED, et al. Bone marrow transplantation for refractory acute leukemia in 34 patients with identical twins. Blood. 1981;57:421.
15. Fefer A, Einstein AB, Thomas ED, et al. Bone marrow transplantation for hematologic neoplasia in 16 patients with identical twins. N Engl J Med. 1974;290:1389.
16. Barnes DW, Loutit JF. Acute graft-versus-host disease in recipients of bone marrow from identical twin donors [letter]. Lancet. 1979;2:905.
17. Rappeport J, Mihm M, Reinherz E, Lopansri S, Parkman R. Acute graft-versus-host disease in recipients of bone marrow from identical twin donors. Lancet. 1979;2:717.
18. Einsele H, Ehninger G, Schneider EM, et al. High frequency of graft-versus-host-like syndromes following syngeneic bone marrow transplantation. Transplantation. 1988;45:579.
19. Hood AF, Vogelsang GB, Black LP, Farmer ER, Santos GW. Acute graft-vs-host disease: development following autologous and syngeneic bone marrow transplantation. Arch Dermatol. 1987; 123:745.
20. Witherspoon RP, Kopecky K, Storb RF, et al. Immunological recovery in 48 patients following syngeneic marrow transplantation or hematological malignancy. Transplantation. 1982;33:143.
21. Hartung G, Uharek L, Zeis M, et al. Superior anti-leukemic activity of murine peripheral blood progenitor cell (PBPC) grafts mobilized by G-CSF and stem cell factor (SCF) as compared to G-CSF alone. Bone Marrow Transplant. 1998; 21(suppl 3):S16.